Chin B. Eap, PhD

JCP
Associations of Valproate Doses With Weight Gain in Psychiatric Patients
Original Research

March 27, 2024

Valproate dose increase of 500 mg was associated with a weight change of +0.52% per month over a year. No associations were found between valproate dose and blood glucose,...
, , , et al
JCP
Daily Dose Effects of Risperidone on Metabolic Parameters
Original Research

May 9, 2022

This study investigated whether dose is a factor in the development of metabolic side effects with atypical antipsychotics.
, , , et al
JCP
Original Research

March 31, 2020

Psychiatric patients are susceptible to cardiovascular disease (CVD), but this risk is poorly understood. This study compared CVD risk in psychiatric patients taking weight gain-inducing drugs with that in...
, , , et al
JCP
Original Research

April 9, 2019

How bad is too bad? Lipid worsening of 5% or more in the early stages of treatment with SGAs predicts a negative metabolic outcome in adults. Is it the...
, , , et al
JCP
Original Research

November 25, 2015

, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe